Delivery Order GS02F0154R-W9133L12F0033

Award Date 5/16/12
Potential Completion Date 11/16/13
Potential Value $5M
Funding Federal Agency
National Capital Region IADS
Contracting Federal Agency
Readiness Center
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Daytona Beach, FL 32114, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded Travere Therapeutics, Inc. a firm fixed price delivery order to provide THIOLA 100 MG, a pharmaceutical product used to treat rare diseases affecting kidney and liver function. This award is issued against Travere's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which serves as the primary vehicle for these types of orders. The delivery order has a potential value of $11,125.32 and a completion date of...
United Therapeutics Corporation has been awarded a $15,649.11 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of TYVASO 64 MCG ORAL INH KIT to Bartlett, Tennessee, with performance required by March 16, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB for the purpose of...
United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract to provide TYVASO 0.6MG/ML to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order has a completion date of April 28, 2023 and was awarded on April 2, 2023. No set-aside designation was used for this award. Performance will take place...
United Therapeutics Corporation has been awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract for the provision of TYVASO (TREPROSTINIL) 0.6MG/ML refill kits to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order, valued at fourteen thousand two hundred twenty-one dollars and thirty-two cents ($14,221.32), has a period of performance through May 1, 2023 to deliver the...
United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for the drug TYVASO (NDC: 66302-0206-02) and has a completion date of May 26, 2023. Performance will take place in Silver Spring, Maryland. No set-aside designation was applied to this order issued under Master GSA...
United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of TYVASO 0.6 refill kits to a location in Bartlett, Tennessee, with work to be completed by March 24, 2023. No set-aside designation was applied to this order placed under GSA Schedule contract...
United Therapeutics Corporation has been awarded a $14,221.32 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for the delivery of TYVASO 0.6 refill kits to a location in Bartlett, Tennessee, with work to be completed by June 2, 2023. No set-aside designation was applied to this order placed under the GSA Pharmaceuticals...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $31,521.74 contract is for the supply of Thiola 100 mg, a medication used to treat cystinuria. The award was made under Travere's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA. Travere also holds two $25 million Blanket Purchase Agreements (BPAs)...
United Therapeutics Corporation has received a $14,693.62 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply TYVASO .6MG/ML REFILL NDC 66302-0206-02 with a completion date of March 9, 2024. This order was placed against United Therapeutics' GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) with no set-aside designation. United Therapeutics has received over 50 similar orders under...
Travere Therapeutics, Inc. was awarded a $18,542.20 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to supply Thioproin pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) for products to be delivered to the VA medical facility located in San Diego, California by June 2024. No set-aside designation was applied to this...

CAV-T/UGT-1

Posted 5/16/12, 12:00 AM